Where does Lumenis BE Ltd. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Lumenis BE Ltd. ranks #15,434 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Lumenis BE Ltd. hold?

Lumenis BE Ltd. holds 19 US utility patents granted between 2022 and 2025, spanning 7 technology areas.

What is Lumenis BE Ltd.'s Innovation Score?

Lumenis BE Ltd. has an Innovation Score of 44.3 out of 100 (top 26% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Lumenis BE Ltd. focus on?

Lumenis BE Ltd.'s top technology area is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy) with 8 patents, ranking #457 of 1,943 assignees active in that subclass. Grants appear in 7 CPC subclasses total.

Is Lumenis BE Ltd.'s patent grant rate increasing or decreasing?

Insufficient historical data is available to calculate a velocity trend for Lumenis BE Ltd..

What does claim depth mean for Lumenis BE Ltd.'s patents?

Lumenis BE Ltd.'s patents average 7.6 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Lumenis BE Ltd. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Lumenis BE Ltd.

USPTO PatentsView assignee record - 19 granted patents across 7 technology areas, recorded in grant years 2022–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Lumenis ranks #15,434 of 49,997 tracked US assignees by granted-patent volume, with 19 patents across 7 technology areas.

#15,434
of 49,997 US assignees by volume: Top 26%
by Innovation Score (44.3/100): 7.6
avg claims per patent

USPTO PatentsView assignee plate

Corpus R15434 · Foreign Corporation #15,434 · 19 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-SPARSE · TYPE-FRNCORP · SPAN-YRS · BOOK-RICH

GRANTS-MICRO 19 grants
MID-PACK #15,434/49,997
PHOTO-FINISH Laplace Interventional
CPC-NARROW A61N · 7 areas
INNOV-PAR 44.3/100
CLAIMS-SPARSE 7.6 claims/avg
TYPE-FRNCORP Foreign Corp
SPAN-YRS 2022–2025 · 4y
BOOK-RICH 9/10 fields

Nearest grant-volume peer: Laplace Interventional Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Lumenis’s 44.3 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 10.3 pts (23%) Velocity 20.0 pts (45%) Breadth 9.4 pts (21%) Claim depth 4.5 pts (10%)

Qualcomm Incorporated · highest

85
Lumenis BE · this assignee

44
3D Lighting… · lowest

7

What this shows Lumenis's Innovation Score is 44.3/100 (top 26% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Lumenis?

Each dot is one of Lumenis’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Lumenis’s own 7.6 claims/patent is at or below the 14.2 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Lumenis vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Lumenis's grants concentrate

Lumenis BE Ltd. is a focused PatentsView assignee: 7 CPC subclasses with 42.1% of grants classified under A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy). Peak complete grant year is 2023 (8 grants) versus a trough of 3 in 2024. By volume, Lumenis sits between Lightbits Labs Ltd. and Level Home, Inc..

Lumenis's three-year grant acceleration

Lumenis BE Ltd. shows 16 grants in 2022–2024 against only 0 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Lightbits Labs

19
Ligitek

19
Longi Green Energ…

19
Lsil &

19
Lynxi

19
Laplace Intervent…

19
Leprino Foods

19
Level Home

19
Lumenis BE ◀

19

What this shows Lumenis holds 19 patents at rank #15,422, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Lumenis

By rank, the assignees closest to #15,422 in granted patent volume.

Leaders in A61N (Electrotherapy)

Other assignees with the most granted patents in Lumenis's primary technology class.

Lumenis's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

44 Top 26% higher than 74% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2022–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2022–2019 baseline. Full figures in the table below.

View data table

Lumenis BE Ltd. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2022	5	26.3%
2023	8	42.1%
2024	3	15.8%
2025partial year	3	15.8%

Which technologies does Lumenis BE Ltd. patent most?

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 8

A61B - DIAGNOSIS; SURGERY; Identification 7

G02B - Optical Elements, Systems OR Apparatus 3

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 2

H01S - Devices Using THE Process OF Light Amplification BY Stimulated Emission OF Radiation [LASER] TO Amplify OR Generate LIGHT; Devices Using Stimulated Emission OF Electromagnetic Radiation IN Wave Ranges Other Than Optical 1

B23K - Soldering OR UNSOLDERING; WELDING; Cladding OR Plating BY Soldering OR WELDING; Cutting BY Applying Heat Locally, e.g. Flame CUTTING; Working BY Laser Beam 1

A61H - Physical Therapy Apparatus, e.g. Devices FOR Locating OR Stimulating Reflex Points IN THE BODY; Artificial RESPIRATION; MASSAGE; Bathing Devices FOR Special Therapeutic OR Hygienic Purposes OR Specific Parts OF THE Body 1

Top 7 of 7 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Lumenis BE Ltd.'s patent record in context - here's where to go next.

Lumenis BE Ltd.'s lead technology class is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy), 42.1% of its portfolio - see every assignee active in that class. Explore A61N
Ranked #15,434 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Lumenis BE Ltd. against Lightbits Labs Ltd., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 44.3/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.